PharmaCyte Biotech (PMCB) had the highest return in 2008 by a US stock or US stock, returning 27,947.6%.
| ASSET | YEAR | % RETURN |
|---|---|---|
PharmaCyte Biotech (PMCB) | 2008 | 27,947.62% |
Arena (AREN) | 2008 | 13,175.86% |
Oxley Bridge Acquisition Limited Class A Ordinary Shares (OBA) | 2008 | 5,749.06% |
TOMI Environmental Solutions (TOMZ) | 2008 | 1,650% |
LifeMD (LFMD) | 2008 | 1,483.33% |
INVO Fertility (IVF) | 2008 | 1,275% |
Quantum Computing (QUBT) | 2008 | 1,250% |
Versus Systems Inc. (VS) | 2008 | 668% |
374Water Inc Common Stock (SCWO) | 2008 | 471.43% |
Emergent Biosolutions (EBS) | 2008 | 421.16% |
MiMedx (MDXG) | 2008 | 339.96% |
Lineage Cell Therapeutics (LCTX) | 2008 | 331.75% |
Crawford (CRD.B) | 2008 | 251.21% |
Sanara Medtech (SMTI) | 2008 | 231.68% |
Mexco Energy (MXC) | 2008 | 209.75% |
Brand House Collective (TBHC) | 2008 | 178.95% |
Metalla Royalty & Streaming (MTA) | 2008 | 171.43% |
Duos Technologies (DUOT) | 2008 | 160% |
Ammo (POWW) | 2008 | 150% |
New Concept Energy (GBR) | 2008 | 137.71% |
Where Food Comes From (WFCF) | 2008 | 114.29% |
Axogen (AXGN) | 2008 | 111.54% |
NanoViricides (NNVC) | 2008 | 107.69% |
Intrusion (INTZ) | 2008 | 94.44% |
Trex (TREX) | 2008 | 90.51% |
